Search Results - Guardado, Moises

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Evidence for a novel, effective approach to targeting carcinoma catabolism exploiting the first-in-class, anti-cancer mitochondrial drug, CPI-613

    Evidence for a novel, effective approach to targeting carcinoma catabolism exploiting the first-in-class, anti-cancer mitochondrial drug, CPI-613 by Guardado Rivas, Moises O, Stuart, Shawn D, Thach, Daniel, Dahan, Michael, Shorr, Robert, Zachar, Zuzana, Bingham, Paul M

    Published in PloS one
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Abstract 2867: FDG-PET imaging as a potential biomarker of mitochondrial targeting by CPI-613, a novel inhibitor of mitochondrial metabolism

    Abstract 2867: FDG-PET imaging as a potential biomarker of mitochondrial targeting by CPI-613, a novel inhibitor of mitochondrial metabolism by Sai, Kiran Solingapuram, Zachar, Zuzana, Almaguel, Frankis, Stuart, Shawn D., Dahan, Michael S., Guardado, Moises, Rideout, Stephanie, Wang, Minghui, Sattiraju, Anirudh, Bingham, Paul M., Pasche, Boris, Mintz, Akiva

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Abstract A61: Tumor metabolic remodeling can modulate anticancer drug response: CPI-613 attack on tumor cell mitochondrial metabolism is mediated by metabolite availability

    Abstract A61: Tumor metabolic remodeling can modulate anticancer drug response: CPI-613 attack on tumor cell mitochondrial metabolism is mediated by metabolite availability by Stuart, Shawn D., Guardado, Moises, Dahan, Michael, Bingham, Paul M., Zachar, Zuzana

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Evidence for a novel, effective approach to targeting carcinoma catabolism exploiting the first-in-class, anti-cancer mitochondrial drug, CPI-613

    Evidence for a novel, effective approach to targeting carcinoma catabolism exploiting the first-in-class, anti-cancer mitochondrial drug, CPI-613 by Moises O Guardado Rivas, Shawn D Stuart, Daniel Thach, Michael Dahan, Robert Shorr, Zuzana Zachar, Paul M Bingham

    Published in PloS one
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: